AbbVie

Últimas noticias

Titulares en el idioma original de la fuente.

• 
  Prediction: Eli Lilly Could Be the Next $2 Trillion Drugmaker (se abre en una pestaña nueva)

  2 oct 2026

• 
  Can ABBV's New Parkinson's Pill Strengthen Its Neuroscience Franchise? (se abre en una pestaña nueva)

  2 oct 2026

• 
  J&J's Innovative Medicine Segment in Q3: Key Growth Drivers to Watch (se abre en una pestaña nueva)

  2 oct 2026

• 
  How Has Pfizer's Story Changed? (se abre en una pestaña nueva)

  2 oct 2026

• AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? (se abre en una pestaña nueva)

  The Motley Fool · 1 oct 2026

• Johnson & Johnson vs. Eli Lilly: Which Pharma Stock Can Make Your Portfolio Healthier in 2026? (se abre en una pestaña nueva)

  1 oct 2026

• AbbVie (ABBV) Stock May Be 41% Undervalued Following JUVMO Approval (se abre en una pestaña nueva)

  Yahoo Finance · 1 oct 2026

• 3 takeaways from a European obesity scientific meeting (se abre en una pestaña nueva)

  1 oct 2026

• What Is The Options Market Telling Us About Eli Lilly Stock? (se abre en una pestaña nueva)

  1 oct 2026

• AbbVie Presents Long-Term RINVOQ® (upadacitinib) Data Showing Continued Repigmentation in Non-Segmental Vitiligo (se abre en una pestaña nueva)

  1 oct 2026

• AbbVie to Host Third-Quarter 2026 Earnings Conference Call (se abre en una pestaña nueva)

  Investing News Network · 1 oct 2026

• 
  5 Solid Dividend Stocks to Buy Now (se abre en una pestaña nueva)

  1 oct 2026

• AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It (se abre en una pestaña nueva)

  1 oct 2026

• 5 High-Yield Dividend Stocks That Pass the Coverage Test (Not Just the Yield Test) (se abre en una pestaña nueva)

  1 oct 2026

• ABBV Stock Rises 25% in 6 Months: Time to Buy, Hold or Sell? (se abre en una pestaña nueva)

  1 oct 2026

• Was The Run In JNJ Stock Hiding In Plain Sight? (se abre en una pestaña nueva)

  30 sept 2026

• AbbVie Stock: Buy, Sell, or Hold in October? (se abre en una pestaña nueva)

  The Motley Fool · 30 sept 2026

• 3 Healthcare Dividend Stocks Offering More Than Just Income (se abre en una pestaña nueva)

  30 sept 2026

• Are You Overpaying For Pfizer Stock Versus Its Rivals? (se abre en una pestaña nueva)

  30 sept 2026

• What Does AbbVie (ABBV) Need To Prove After Its Eczema Drug And AI Update? (se abre en una pestaña nueva)

  Yahoo Finance · 30 sept 2026

• What Is Merck Stock's Biggest Opportunity? (se abre en una pestaña nueva)

  Trefis · 30 sept 2026

• 1 Profitable Stock to Keep an Eye On and 2 Facing Challenges (se abre en una pestaña nueva)

  StockStory · 30 sept 2026

• BofA Boosts AbbVie and J&J Price Targets on Growth and Pipeline Strength (se abre en una pestaña nueva)

  24/7 Wall St. · 30 sept 2026

• AbbVie reports positive phase 2 data for Zumilokibart in atopic dermatitis (se abre en una pestaña nueva)

  Seeking Alpha · 30 sept 2026

• AbbVie Highlights Positive Results from the Phase 2 APEX Part B Study of Zumilokibart in Moderate to Severe Atopic Dermatitis, as a Late Breaker at EADV 2026 (se abre en una pestaña nueva)

  Yahoo Finance · 30 sept 2026

• AbbVie (ABBV) Falls More Steeply Than Broader Market: What Investors Need to Know (se abre en una pestaña nueva)

  Zacks · 29 sept 2026

• Defensive Dividends: 3 Companies Investors Can Rely On (se abre en una pestaña nueva)

  Zacks · 29 sept 2026

• Is Eli Lilly Stock a Good Fit For Your Portfolio Risk? (se abre en una pestaña nueva)

  Trefis · 29 sept 2026

• Final Trade: Abbvie, Advanced Micro, SpaceX, Eaton Corp. (se abre en una pestaña nueva)

  CNBC · 29 sept 2026

• Amazon, Walmart Surplus Auctioneer Climbs Toward A Breakout; Stock Up 45% (se abre en una pestaña nueva)

  Investor's Business Daily · 29 sept 2026